CDTX stock · META stock

CDTX vs META · rev $1.3M vs P/E 29, rev $200.97B

Cidara Therapeutics Inc (CDTX) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.

Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.

Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.

Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.

Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.

CDTX currently screens at market cap $6.96B. META currently screens at market cap $1.64T and trailing P/E 28.8.

Not investment advice. Open the CDTX and META stock pages for the full models.

Not investment advice.

Popular Stock Comparisons